Keyphrases
Frameshift mutation
100%
Medullary Thyroid Carcinoma
100%
ESR2
100%
Medullary Thyroid Cancer
54%
Germ Cells
27%
RET mutation
27%
Multiple Endocrine Neoplasia Type 2 (MEN2)
18%
Protein Level
9%
Susceptibility Genes
9%
Estrogen
9%
Transcriptional Activity
9%
Estrogen Receptor 1 (ESR1)
9%
MRNA Expression
9%
MRNA Level
9%
Missense
9%
Pathological Diagnosis
9%
Cancer Development
9%
Predisposing Genes
9%
Luciferase Activity
9%
Cancer Predisposition
9%
Single Amino Acid Substitution
9%
Functional Assay
9%
Thyroid Surgery
9%
HCT116 Cells
9%
Gene Alteration
9%
HCT116
9%
Sequencing Studies
9%
Exome Sequencing
9%
4-hydroxytamoxifen
9%
RET Proto-oncogene
9%
Biochemistry, Genetics and Molecular Biology
Germ Cell
100%
Frameshift Mutation
100%
Germline
100%
Messenger RNA
66%
Gene Mutation
33%
Agonist
33%
Amino Acid Substitution
33%
RET Proto-Oncogene
33%
Missense
33%
Luciferase
33%
Nicotinamide Adenine Dinucleotide
33%
Exome Sequencing
33%
Medicine and Dentistry
Frameshift Mutation
100%
Thyroid Cancer
100%
Thyroid Medullary Carcinoma
100%
Germ Cell
50%
Messenger RNA
33%
Multiple Endocrine Neoplasia Type 2
33%
Disease Predisposition
16%
Gene Mutation
16%
Cancer Susceptibility
16%
Proto Oncogene
16%
Nicotinamide Adenine Dinucleotide
16%
Thyroid Surgery
16%
Amino Acid Substitution
16%
Luciferase
16%
Exome Sequencing
16%
Afimoxifene
16%
Histology
16%
Neuroscience
Thyroid
100%
Frameshift Mutation
100%
Germ Cell
37%
Messenger RNA
25%
Endocrine Neoplasia
25%
Agonist
12%
Gene Mutation
12%
Luciferase
12%
Amino Acid Substitution
12%
Exome Sequencing
12%
RET Proto-Oncogene
12%
Afimoxifene
12%
Histology
12%
Immunology and Microbiology
Frameshift Mutation
100%
Thyroid
100%
Germ Cell
37%
Gene Mutation
12%
Amino Acid Substitution
12%
Agonist
12%
Proto Oncogene
12%
Whole Exome Sequencing
12%